The Acute Gout Flare Therapeutics Market is estimated to be valued at USD 2.59 billion in 2025 and is expected to reach USD 3.47 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.4% from 2025 to 2032. https://logcla.com/blogs/601063/Acute-Gout-Flare-Therapeutics-Market-to-Grow-on-Innovative-Drugs